HHS Secretary Robert F. Kennedy Jr. said the curve is flattening in the measles outbreak in Texas. Public health experts say ...

Could a gene regulatory network in gut microbes have evolved its elaborate and tightly regulated molecular machinery only to ...

Saccharin, the artificial sweetener used in diet foods like yogurts and sugar-free drinks, can kill multidrug-resistant ...

This important study analyzes the effect of heat treatment on phage-bacterial interactions and convincingly shows that prior heat exposure alters the bacterial cell envelope, enhancing persistence and ...

This important study shows that the Nora virus, a natural Drosophila pathogen that also persistently infects many laboratory fly stocks, infects intestinal stem cells (ISCs), leading to a shorter life ...

Exposure to antibiotics during a key developmental window in infancy can stunt the growth of insulin-producing cells in the ... of the human infant microbiome—the constellation of bacteria and fungi ...

Growth stocks are typically rapidly expanding younger companies with above-average growth rates. While growth investing can be a hugely rewarding, this investing strategy also comes with high risks ...

I now consider this IP one of ZLAB’s main growth drivers. ZLAB’s ongoing strategy of focusing on Chinese approvals continues to pay off with Vyvgart Hytrulo, Xacduro, and Augtyro in oncology ...

Growth stocks can provide high returns but are volatile and suffered in 2022, rebounding in 2023-24. They often have higher price-to-earnings ratios, focusing on companies with innovative products ...

Wage growth has remained strong, the latest official figures show, as the Bank of England decided to hold interest rates. Wages - excluding bonuses - grew 5.9% in the three months to January ...

The s-shaped growth curve is a staple of business strategy. It explains everything from product adoption to corporate growth—slow emergence, rapid acceleration, and eventually, a plateau.